These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34039232)

  • 1. Effects of the Medicare Part D comprehensive medication review on medication adherence among patients with Alzheimer's disease.
    Dong X; Tsang CCS; Zhao S; Browning JA; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Hines LE; Wang J
    Curr Med Res Opin; 2021 Sep; 37(9):1581-1588. PubMed ID: 34039232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.
    Browning JA; Tsang CCS; Dong X; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Liu C; Wang J
    BMC Health Serv Res; 2022 Feb; 22(1):159. PubMed ID: 35130899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.
    Dong X; Tsang CCS; Zhao S; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Am Health Drug Benefits; 2021 Sep; 14(3):101-109. PubMed ID: 35261713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.
    Steve Tsang CC; Browning J; Todor L; Dougherty S; Hohmeier KC; Sam Li M; Borja-Hart N; Hines LE; Wang J
    J Manag Care Spec Pharm; 2021 Aug; 27(8):971-981. PubMed ID: 34337985
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review Recipients.
    Dong X; Tsang CCS; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Explor Res Clin Soc Pharm; 2021 Sep; 3():. PubMed ID: 35434697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Medicare Part D medication therapy management on racial/ethnic disparities in adherence to antidementia medications among patients with Alzheimer's disease and related dementias: An observational study.
    Dong X; Tsang CCS; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Browning JA; Garuccio J; Zeng R; Wang J
    Explor Res Clin Soc Pharm; 2024 Mar; 13():100420. PubMed ID: 38420610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between comprehensive medication review and medication adherence among medicare beneficiaries with chronic obstructive pulmonary disease.
    Zhang X; Sim Y; Tsang CCS; Wang J; Finch CK
    Explor Res Clin Soc Pharm; 2024 Sep; 15():100470. PubMed ID: 39050144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence.
    Ferries E; Dye JT; Hall B; Ndehi L; Schwab P; Vaccaro J
    J Manag Care Spec Pharm; 2019 Jun; 25(6):688-695. PubMed ID: 31134865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Opioid Use and Mental Illness on Chronic Disease Medication Adherence in Superutilizers.
    Surbhi S; Graetz I; Wan JY; Gatwood J; Bailey JE
    J Manag Care Spec Pharm; 2018 Mar; 24(3):198-207. PubMed ID: 29485952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.
    Browning JA; Tsang CCS; Zeng R; Dong X; Garuccio J; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Wang J
    Curr Med Res Opin; 2022 Oct; 38(10):1715-1725. PubMed ID: 35852087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management.
    Coe AB; Adeoye-Olatunde OA; Pestka DL; Snyder ME; Zillich AJ; Farris KB; Farley JF
    Res Social Adm Pharm; 2020 Sep; 16(9):1208-1214. PubMed ID: 31859225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities associated with Medicare Part D Star Ratings measures among patients with Alzheimer's disease and related dementias.
    Tsang CCS; Zhang X; Barenie RE; Cernasev A; Miller NA; Wan JY; Tsao JW; Wang J
    Medicine (Baltimore); 2023 May; 102(18):e33641. PubMed ID: 37144996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.
    Steve Tsang CC; Wan JY; Chisholm-Burns MA; Li M; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Res Social Adm Pharm; 2021 Aug; 17(8):1469-1477. PubMed ID: 33272859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding reasons for nonadherence to medications in a medicare part d beneficiary sample.
    Hincapie AL; Taylor AM; Boesen KP; Warholak T
    J Manag Care Spec Pharm; 2015 May; 21(5):391-9. PubMed ID: 25943000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of comprehensive medication reviews on potentially inappropriate medication discontinuation in Medicare beneficiaries.
    Hung A; Wilson LE; Smith VA; Pavon JM; Sloan CE; Hastings SN; Maciejewski ML
    J Am Geriatr Soc; 2024 Aug; 72(8):2347-2358. PubMed ID: 38826070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of medication therapy management on medication utilization among Medicare beneficiaries with HIV/AIDS.
    Zhang X; Wang J
    J Am Pharm Assoc (2003); 2024; 64(2):463-470.e2. PubMed ID: 38182001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.
    Zhang Y; Lave JR; Donohue JM; Fischer MA; Chernew ME; Newhouse JP
    Med Care; 2010 May; 48(5):409-17. PubMed ID: 20393360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Much Does Medication Nonadherence Cost the Medicare Fee-for-Service Program?
    Lloyd JT; Maresh S; Powers CA; Shrank WH; Alley DE
    Med Care; 2019 Mar; 57(3):218-224. PubMed ID: 30676355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014.
    Ritchey M; Chang A; Powers C; Loustalot F; Schieb L; Ketcham M; Durthaler J; Hong Y
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(36):967-76. PubMed ID: 27632693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription drug coverage satisfaction, cost-reducing behavior, and medication nonadherence among Medicare beneficiaries with type 2 diabetes.
    He Q; Silverman CL; Park C; Tiu GF; Ng BP
    J Manag Care Spec Pharm; 2021 Jun; 27(6):696-705. PubMed ID: 34057396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.